Simba Gill Evelo Biosciences, Inc. (EVLO) insider trading activity

Simba Gill is President & CEO of Evelo Biosciences, Inc.. Currently has a direct ownership of 17,758 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 172 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $56. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.8K

0% 3M change

5.97% 12M change

Total Value Held $0

SIMBA GILL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Open market or private sale	$56 $0.33 p/Share	172 Reduced 0.96%	17,758 Common Stock
Nov 07 2023	BUY Exercise of conversion of derivative security	-	1,172 Added 6.14%	17,930 Common Stock
Sep 28 2023	SELL Open market or private sale	$7,864 $3.94 p/Share	1,996 Reduced 10.64%	16,758 Common Stock
Sep 27 2023	BUY Exercise of conversion of derivative security	-	15,000 Added 44.44%	18,754 Common Stock
Aug 08 2023	SELL Open market or private sale	$3,252 $9.51 p/Share	342 Reduced 8.35%	3,754 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	-	1,171 Added 22.23%	4,096 Common Stock
May 08 2023	SELL Open market or private sale	$459 $0.13 p/Share	3,537 Reduced 5.7%	58,512 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	23,437 Added 27.42%	62,049 Common Stock

Also insider at

FHTX

Foghorn Therapeutics Inc. Healthcare

AGE

AgeX Therapeutics, Inc. Healthcare

Director

Simba Gill

President & CEO

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Value

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evelo Biosciences, Inc.

Track Activities on EVLO

Account